In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
The Indian Air Force is equipping Sukhoi (SU-30) fighter jets with new missiles to give a befitti
Iran has been severely punished for brutally suppressing anti-hijab protests. On Wednesday, she w
The question has once again arisen on the security of foreigners in Afghanistan. On Monday, some
Vivo X90 series launched renders of Samsung Galaxy S23 excited, see all the special features of both
Vivo X90 Series: Vivo X90 5G series was launched in China on 22 November 2022. In this series, th
Union Minister Prahlad Patel said that soon a law will be brought for population control. Patel s
The second wave of Corona affected Maharashtra the most. Now the situation is slowly getting bett
Opposition to the Agneepath scheme of the Central Government for recruitment in the army has star
Lucknow Supergiants all-rounder Marcus Stoinis shattered the pride of Chennai Super Kings in
Gujarat Election: BJP said, corruption is studied in AAP's education model, Sisodia attacks PM
Arvind Kejriwal takes every election campaign ahead of Delhi's education and health model. Even i
Three cases including murder have been registered against Haryana's Gurmel who was arrested in th
